Company: SMNR
Filing Date: 2025-10-21
Form Type: S-1
Source: 0001193125-25-245178
Chunk: 337

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-10-21
Form: S-1
Chunk 337
---
 registered public accounting firm, as stated in their report (which report expresses an unqualified opinion and includes explanatory paragraphs relating to a going concern uncertainty and the use of a carve-out basis of accounting discussed in Notes 1 and 2), which is included herein. Such financial statements are included in reliance upon the report of such firm given their authority as experts in accounting and auditing.

<div align='center'>**217

TRANSFER AGENT AND REGISTRAR**</div>

The transfer agent for our securities is VStock.

<div align='center'>**WHERE YOU CAN FIND MORE INFORMATION**</div>

We have filed a registration statement on Form S-1, including exhibits, under the Securities Act, with respect to the securities offered by this prospectus. This prospectus does not contain all of the information included in the registration statement. For further information pertaining to us and our securities, you should refer to the registration statement of which this prospectus is a part and the exhibits to such registration statement. The descriptions in this prospectus of the provisions of documents filed as exhibits to this prospectus are only summaries of those documents’ material terms. You can read copies of such documents, along with copies of reports, proxy statements and other information filed by us with the SEC at the SEC’s website at http://www.sec.gov.

We also maintain a website at www.semnurpharma.com. Through our website, we make available, free of charge, annual, quarterly and current reports, proxy statements and other information as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC. The information contained on, or that may be accessed through, our website is not part of, and is not incorporated into, this prospectus and the inclusion of our website address in this prospectus is an inactive textual reference only

<div align='center'>218</div>

INDEX TO FINANCIAL STATEMENTS DENALI CAPITAL ACQUISITION CORP.

| FINANCIAL STATEMENTS:                                                                                       |     |      |
| Report of Independent Registered Public Accounting Firm Marcum Asia CPAs LLP (PCAOB ID Number 5395)         |     | F-2  |
| Report of Independent Registered Public Accounting Firm Marcum LLP (PCAOB ID Number 688)                    |     | F-4  |
| Consolidated Balance Sheets as of December 31, 2024 and 2023                                                |     | F-6  |
| Consolidated Statements of Operations for the years ended December 31